Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair

Accomplished CFO and Board Leader to Provide Independent Leadership to Deliver on Company’s Growth Strategy BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of Emma Reeve as an independent board […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content